Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD

NEUROPSYCHOLOGIA

卷:51

Article

Wolk, David A.^1,2  Mancuso, Lauren^1,2  Kliot, Daria^1,2  Arnold, Steven E.^1,2,3  Dickerson, Bradford C.^4,5,6,7 

[1] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Penn Memory Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA

[3] Univ Penn, Dept Psychiat, Perelman Sch Med, Philadelphia, PA 19104 USA

[4] Massachusetts Gen Hosp, Frontotemporal Dementia Unit, Boston, MA 02114 USA

[5] Massachusetts Gen Hosp, Massachusetts Alzheimers Dis Res Ctr, Boston, MA 02114 USA

[6] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA

[7] Harvard Univ, Sch Med, Boston, MA USA

关键词: Memory;    Recollection;    Familiarity;    Alzheimer's disease;    Medial temporal lobe;    Preclinical Alzheimer's disease;    Mild cognitive impairment;   

DOI  :  10.1016/j.neuropsychologia.2013.02.014

来源: Elsevier

【 摘 要 】

There is great interest in the development of cognitive markers that differentiate normal age-associated cognitive change from that of Alzheimer's disease (AD) in its prodromal (i.e., mild cognitive impairment; MCI) or even preclinical stages. Dual process models posit that recognition memory is supported by the dissociable processes of recollection and familiarity. Familiarity-based memory has generally been considered to be spared during normal aging, but it remains controversial whether this type of memory is impaired in early AD. Here, we describe findings of estimates of recollection and familiarity in young adults (YA), cognitively normal older adults (CN), and patients with amnestic-MCI (a-MCI). These measures in the CN and a-MCI patients were then related to a structural imaging biomarker of AD that has previously been demonstrated to be sensitive to preclinical and prodromal AD, the Cortical Signature of AD (ADsig). Consistent with much work in the literature, recollection, but not familiarity, was impaired in CN versus YA. Replicating our prior findings, a-MCI patients displayed impairment in both familiarity and recollection. Finally, the familiarity measure was correlated with the ADsig biomarker across the CN and a-MCI group, as well as within the CN adults alone. No other standard psychometric measure was as highly associated with the ADsig, suggesting that familiarity may be a sensitive biomarker of AD-specific brain changes in preclinical and prodromal AD and that it may offer a qualitatively distinct measure of early AD memory impairment relative to normal age-associated change. (C) 2013 Elsevier Ltd. All rights reserved.

【 授权许可】

Free